Britannia Industries Ltd. - Research Center
500825 BRITANNIA Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Sales | 3,924.24 | 4,102.36 | 4,288.85 | 3,870.63 | 3,894.73 |
| Operating profit | 770.39 | 792.86 | 840.94 | 666.63 | 794.69 |
| Interest | 25.84 | 29.22 | 47.95 | 48.39 | 29.59 |
| Gross profit | 799.71 | 813.25 | 846.17 | 670.40 | 818.33 |
| EPS (Rs) | 22.01 | 22.35 | 23.68 | 18.39 | 23.17 |
Quarterly
results in details
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Other income | 55.16 | 49.61 | 53.18 | 52.16 | 53.23 |
| Stock adjustment | -2.26 | 18.60 | -16.24 | -0.09 | 2.92 |
| Raw material | 1,773.61 | 1,843.50 | 1,987.69 | 1,789.94 | 1,716.61 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 124.89 | 163.19 | 125.05 | 152.15 | 136.53 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,257.61 | 1,284.21 | 1,351.41 | 1,262.00 | 1,243.98 |
| Provisions made | - | - | - | - | - |
| Depreciation | 72.70 | 70.71 | 64.43 | 63.35 | 57.51 |
| Taxation | 196.86 | 201.28 | 211.25 | 164.00 | 202.66 |
| Net profit / loss | 530.15 | 538.36 | 570.49 | 443.05 | 558.16 |
| Extra ordinary item | - | -2.90 | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 24.09 | 24.09 | 24.09 | 24.09 | 24.09 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 19.63 | 19.33 | 19.61 | 17.22 | 20.40 |
| GPM (%) | 20.10 | 19.59 | 19.49 | 17.09 | 20.73 |
| NPM (%) | 13.32 | 12.97 | 13.14 | 11.29 | 14.14 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis